| BCBS Federal Medical & Drug | 5.21.229 Lazcluze (lazertinib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.230 Itovebi (inavolisib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.232 Revuforj (revumenib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.233 Ziihera (zanidatamab-hrii) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.234 Ensacove (ensartinib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.235 Unloxcyt (cosibelimab-ipdl) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.236 Aucatyzl (obecabtagene autoleucel) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.237 Bizengri (zenocutuzumab-zbco) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.238 Datroway (datopotamab deruxtecan-dlnk) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.239 Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) | 2026-03-06 |